Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00283322 · ClinicalTrials.gov registry record
Heparin Antibodies in Intensive Care Unit Patients (HAICU)
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 185
- Enrollment target
NCT00283322 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 185 participants.
The verdict
NCT00283322 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 185 participants
- Enrollment target
Study Summary
Intensive care unit patients have multiple risk factors for venous thromboembolism. Venous thromboembolism leads to significant morbidity and can be fatal. Unfractionated heparin and low molecular weight heparin are commonly used to prevent venous thromboembolism. Heparin induced thrombocytopenia, an untoward consequence of exposure to heparin, is an immune disorder that may develop in patients treated with heparin products. Determining the prevalence of heparin induced thrombocytopenia and its relationship to preventive and therapeutic heparin and low molecular weight heparin will help clinicians more appropriately choose methods of venous thromboembolism prophylaxis and treatment in the critically ill, ICU population. The objective of this study is to determine the prevalence of heparin-induced antibodies on admission to the ICU and the development of new heparin-antibodies during the first week of hospitalization.
Interventions
- OTHER blood samples (2)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 2004-11 |
| Est. Completion | 2006-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00283322
The ClinicalTrials.gov registry entry for NCT00283322 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 185 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which blood samples (2) is the first listed.
NCT00283322 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00283322 about?
NCT00283322 is a clinical study titled "Heparin Antibodies in Intensive Care Unit Patients (HAICU)". Intensive care unit patients have multiple risk factors for venous thromboembolism. Venous thromboembolism leads to significant morbidity and can be fatal. Unfractionated heparin and low molecular weight heparin are commonly used to prevent venous thromboembolism. Heparin induced thrombocytopenia, a...
What is the current status of trial NCT00283322?
This trial is currently completed. The enrollment target is 185 participants. The study started on 2004-11. Estimated completion is 2006-05.
What interventions are being tested in trial NCT00283322?
The interventions under investigation include: blood samples (2) (OTHER).
Who is sponsoring clinical trial NCT00283322?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.